---
schema_version: "secwatch.filing_event.v1"
accession: "0001411690-25-000092"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2025-11-13T23:59:59+00:00"
generated_at: "2026-05-16T20:15:14.397416+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bionano Q3 revenue $7.4M (+21% YoY); raises FY 2025 OGM install guidance

## Summary
- Total revenue $7.4M, up 21% from $6.1M in Q3 2024; consumables/software revenue +15%.
- GAAP gross margin 46% vs (139)% a year ago; non-GAAP gross margin 46% vs 26%.
- Operating expenses cut 66% to $11.9M; cash and investments $31.8M at quarter-end.
- Raised FY 2025 OGM system install guidance to >25 units (prior 20-25).
- Reiterated FY 2025 revenue guidance $26-30M; Q4 2025 revenue guided $7.5-7.9M.

## SEC filing metadata
- accession: 0001411690-25-000092
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2025-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000141169025000092/0001411690-25-000092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000141169025000092/bngo-20251113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001411690-25-000092
- JSON: https://secwatch.observer/filing/0001411690-25-000092.json
- Plain text: https://secwatch.observer/filing/0001411690-25-000092.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.